NCT01218971View on ClinicalTrials.gov

ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)

PHASE3CompletedINTERVENTIONAL

Enrollment

332

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions

Alcohol Dependence

Interventions

DRUG

Medisorb naltrexone 190 mg

naltrexone for extended-release injectable suspension

DRUG

Medisorb naltrexone 380 mg

naltrexone for extended-release injectable suspension

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alkermes, Inc.

INDUSTRY